Rapamycin insensitivity in Schistosoma mansoni is not due to FKBP12 functionality

Molecular and Biochemical Parasitology

Volumn 125, Issue 1-2, 2002, Pages 1-9

  Rossi, Alessandro ^a   Pica Mattoccia, Livia ^b   Cioli, Donato ^b   Klinkert, Mo Quen ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CNR   (Italy)

Author keywords

Immunophilin FK506 binding protein; Immunosuppressant rapamycin; Schistosoma mansoni

Indexed keywords

DRUG RECEPTOR; RAPAMYCIN; RECEPTOR FKBP12; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; LIFE CYCLE; MOLECULAR CLONING; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE; SCHISTOSOMA MANSONI; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; WESTERN BLOTTING;

ESCHERICHIA COLI; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE; SCHISTOSOMA; SCHISTOSOMA MANSONI; TOR; VERMES;

EID: 0036860230     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(02)00207-4     Document Type: Article

References (31)

1. Cardenas M.E., Cruz M.C., Del Poeta M., Chung N., Perfect J.R., Heitman J. Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. Clin. Microbiol. Rev. 12:1999;583-611.
2. Bueding E., Hawkins J., Cha Y.N. Antischistosomal effects of cyclosporin A. Agents Actions. 11:1981;380-383.
3. Bell A., Roberts H.C., Chappell L.H. The antiparasite effects of cyclosporin A: possible drug targets and clinical applications. Gen. Pharmacol. 27:1996;963-971.
4. Bell A., Wernli B., Franklin R.M. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Biochem. Pharmacol. 48:1994;495-503.
5. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 226:1984;544-547.
6. Liu J., Farmer J.D. Jr., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
7. Galat A. Sequence diversification of the FK506-binding proteins in several different genomes. Eur. J. Biochem. 267:2000;4945-4959.
8. Jayaraman T., Brillantes A.M., Timerman A.P., et al. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem. 267:1992;9474-9477.
9. Cameron A.M., Steiner J.P., Sabatini D.M., Kaplin A.I., Walensky L.D., Snyder S.H. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc. Natl. Acad. Sci. USA. 92:1995;1784-1788.
10. Wang T., Li B.Y., Danielson P.D., et al. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell. 86:1996;435-444.
11. Griffith J.P., Kim J.L., Kim E.E., et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell. 82:1995;507-522.
12. Heitman J., Movva N.R., Hall M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 253:1991;905-909.
13. Sabatini D.M., Erdjument-Bromage H., Lui M., Tempst P., Snyder S.H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell. 78:1994;35-43.
14. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 357:1992;695-697.
15. Odom A., Muir S., Lim E., Toffaletti D.L., Perfect J., Heitman J. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16:1997;2576-2589.
16. Nakamura T., Liu Y., Hirata D., et al. Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions. EMBO J. 12:1993;4063-4071.
17. Cioli D. Praziquantel: is there real resistance and are there alternatives? Curr. Opin. Infect. Dis. 13:2000;659-663.
18. Klinkert M.Q., Bugli F., Engels B., Carrasquillo E., Valle C., Cioli D. Characterization of a Schistosoma mansoni cDNA encoding a B-like cyclophilin and its expression in Escherichia coli. Mol. Biochem. Parasitol. 75:1995;99-111.
19. Khattab A., Pica-Mattoccia L., Klinkert M.Q., Wenger R., Cioli D. Cyclosporins: lack of correlation between antischistosomal properties and inhibition of cyclophilin isomerase activity. Exp. Parasitol. 90:1998;103-109.
20. Khattab A., Pica-Mattoccia L., Wenger R., Cioli D., Klinkert M.Q. Assay of Schistosoma mansoni calcineurin phosphatase activity and assessment of its role in parasite survival. Mol. Biochem. Parasitol. 99:1999;269-273.
21. Mecozzi B., Rossi A., Lazzaretti P., et al. Molecular cloning of Schistosoma mansoni calcineurin subunits and immunolocalization to the excretory system. Mol. Biochem. Parasitol. 110:2000;333-343.
22. Vaitukaitis J., Robbins J.B., Nieschlag E., Ross G.T. A method for producing specific antisera with small doses of immunogen. J. Clin. Endocrinol. Me. 33:1971;988-991.
23. Kofron J.L., Kuzmic P., Kishore V., Colon-Bonilla E., Rich D.H. Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. Biochemistry. 30:1991;6127-6134.
24. Wach A. PCR-synthesis of marker cassettes with long flanking homology regions for gene disruptions in S. cerevisiae. Yeast. 12:1996;259-265.
25. 2+ ATPases in Saccharomyces cerevisiae. Mol. Cell Biol. 16:1996;2226-2237.
26. 2+ tolerance. J. Biol. Chem. 273:1998;27831-27840.
27. Osman A., Kiang D., Lo Verde P.T., Karim A.M. Schistosoma mansoni: characterization of p50, an immunophilin. Exp. Parasitol. 80:1995;550-559.
28. Van Duyne G.D., Standaert R.F., Karplus P.A., Schreiber S.L., Clardy J. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science. 252:1991;839-842.
29. Choi J., Chen J., Schreiber S.L., Clardy J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science. 273:1996;239-242.
30. Futer O., DeCenzo M.T., Aldape R.A., Livingston D.J. FK506 binding protein mutational analysis. Defining the surface residue contributions to stability of the calcineurin co-complex. J. Biol. Chem. 270:1995;18935-18940.
31. Lorenz M.C., Heitman J. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J. Biol. Chem. 270:1995;27531-27537.